<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>23(11)</volume><submitter>Chukwueke UN</submitter><funding>National Institute of Neurological Disorders and Stroke</funding><funding>National Institutes of Health</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>Neuro-oncology has grown tremendously since 2010, marked by increasing society membership, specialized clinical expertise, and new journals. Yet, modest improvement in racial/ethnic diversity amongst clinical trial participants, researchers, and clinicians led us to conduct a survey to identify opportunities to enhance diversity and inclusiveness amongst neuro-oncology professionals.&lt;h4>Methods&lt;/h4>In summer 2020, the Women and Diversity Committee of the Society for Neuro-Oncology (SNO) distributed an anonymous online survey to members and affiliates including the European Association of Neuro-Oncology (EANO), Asian Society for Neuro-Oncology (ASNO), Society for Neuro-Oncology Latin America (SNOLA) and Society for Neuro-Oncology Sub-Saharan Africa (SNOSSA). The survey ca</pubmed_abstract><journal>Neuro-oncology</journal><pagination>1845-1858</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8563326</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>SNO 2020 diversity survey: defining demographics, racial biases, career success metrics and a path forward for the field of neuro-oncology.</pubmed_title><pmcid>PMC8563326</pmcid><pubmed_authors>Acquaye A</pubmed_authors><pubmed_authors>Jackson S</pubmed_authors><pubmed_authors>Vera E</pubmed_authors><pubmed_authors>Odia Y</pubmed_authors><pubmed_authors>Armstrong TS</pubmed_authors><pubmed_authors>Gatson NTN</pubmed_authors><pubmed_authors>Dunbar E</pubmed_authors><pubmed_authors>Camelo-Piragua S</pubmed_authors><pubmed_authors>Chukwueke UN</pubmed_authors><pubmed_authors>Sharma A</pubmed_authors><pubmed_authors>Thomas AA</pubmed_authors><pubmed_authors>Porter AB</pubmed_authors><pubmed_authors>Hervey-Jumper SL</pubmed_authors><pubmed_authors>Werbowetski-Ogilvie TE</pubmed_authors><pubmed_authors>Klesse LJ</pubmed_authors><pubmed_authors>Fonkem E</pubmed_authors><pubmed_authors>de la Fuente MI</pubmed_authors></additional><is_claimable>false</is_claimable><name>SNO 2020 diversity survey: defining demographics, racial biases, career success metrics and a path forward for the field of neuro-oncology.</name><description>&lt;h4>Background&lt;/h4>Neuro-oncology has grown tremendously since 2010, marked by increasing society membership, specialized clinical expertise, and new journals. Yet, modest improvement in racial/ethnic diversity amongst clinical trial participants, researchers, and clinicians led us to conduct a survey to identify opportunities to enhance diversity and inclusiveness amongst neuro-oncology professionals.&lt;h4>Methods&lt;/h4>In summer 2020, the Women and Diversity Committee of the Society for Neuro-Oncology (SNO) distributed an anonymous online survey to members and affiliates including the European Association of Neuro-Oncology (EANO), Asian Society for Neuro-Oncology (ASNO), Society for Neuro-Oncology Latin America (SNOLA) and Society for Neuro-Oncology Sub-Saharan Africa (SNOSSA). The survey ca</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Nov</publication><modification>2025-04-22T06:51:00.365Z</modification><creation>2025-04-05T21:55:33.83Z</creation></dates><accession>S-EPMC8563326</accession><cross_references><pubmed>34302487</pubmed><doi>10.1093/neuonc/noab172</doi></cross_references></HashMap>